Search
Search Results
Found 12 items.
-
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024421PDF: 180 -
Stroke in women: anticoagulation in a complicated puzzle
Published: 26 August 2024924PDF: 245 -
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
Published: 14 December 2022657PDF: 282 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024294PDF: 105 -
New perspectives for prevention of the post-thrombotic syndrome
Published: 22 March 20221280PDF: 412 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241246PDF: 209 -
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
Published: 15 April 2022519PDF: 192Supplementary Files: 57 -
Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score
Published: 11 October 20231354PDF: 188 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024320PDF: 153 -
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231175PDF: 408 -
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Published: 27 June 20231045PDF: 236Supplementary File: 111 -
Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study
Published: 1 December 20221273PDF: 255
1 - 12 of 12 items